<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of the study is to investigate the effect of salvianolic acid B (SalB) on blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) in rats after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion, and to illustrate its possible mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo>-reperfusion was induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rats </plain></SENT>
<SENT sid="2" pm="."><plain>The break-down of <z:chebi fb="2" ids="33602">BBB</z:chebi> was indicated by extravasations of immunoglobulin (IgG) monitored with immunohistochemistry </plain></SENT>
<SENT sid="3" pm="."><plain>The expression of MMP-9 and NOS2 in the brain was determined by immunohistochemistry, and the expression of p-p38 and p-ERK1/2 was detected by Western blotting </plain></SENT>
<SENT sid="4" pm="."><plain>It was shown that on day 2 after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion the IgG accumulated around the vascular boundary zone, suggesting the break-down of <z:chebi fb="2" ids="33602">BBB</z:chebi>, and the expression of MMP-9 and NOS2 up-regulated at the same time </plain></SENT>
<SENT sid="5" pm="."><plain>The result of Western blotting suggested that the expression of p-p38 and p-ERK1/2 increased </plain></SENT>
<SENT sid="6" pm="."><plain>On day 7 after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion the. expression of MMP-9 and NOS2 was about the same level as day 2, the expression of p-p38 was higher than that on day 2 and the expression of p-ERK1/2 was slightly lower than that on day 2 </plain></SENT>
<SENT sid="7" pm="."><plain>SalB (1 and 10 mg x kg(-1)) significantly alleviated the extravasations of immunoglobulin induced by <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion (P &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>On day 2 and day 7 SalB attenuated the expression of MMP-9 and NOS2 (P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>SalB (10 mg x kg(-1)) reduced the expression of p-p38 and p-ERK1/2 apparently on day 2 and 7 after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion (P &lt; 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>SalB (1 mg x kg(-1)) inhibited the expression of p-p38 on day 7 after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion (P &lt; 0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>The results indicate that SalB protects blood-brain barrier in rats after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion by inhibiting the MAPK pathway </plain></SENT>
</text></document>